Saturday 23 November 2013

AHA: Mixed Data for Warfarin Dosing By Genotype (CME/CE)

DALLAS (MedPage Today) -- For patients requiring anticoagulation for atrial fibrillation, venous thromboembolism, or some other indication, genotype-guided dosing of warfarin and similar drugs might have some benefit, three trials showed. (Source: MedPage Today Cardiovascular)

Source: http://www.medworm.com/index.php?rid=7772690&cid=u_0_7_f&fid=29192&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAHA%2F43021

phlebotomy training in virginia phlebotomy training in fayetteville nc phlebotomy certification in florida

No comments:

Post a Comment